Literature DB >> 8970013

The cognitive assessment screening test (CAST) for dementia.

D A Drachman1, J M Swearer, K Kane, D Osgood, C O'Toole, M Moonis.   

Abstract

The purpose of this study was to assess the usefulness, the sensitivity, and the specificity of the Cognitive Assessment. Screening Test (CAST), a paper-and-pencil self-administered cognitive test designed to screen elderly people for possible dementia, for use in general physicians' offices, requiring little expertise or staff time. CAST consists of three parts: part A (relatively easy), part B (more demanding), and part C (self-report of concerns). CAST was administered in two studies to: (1) 19 patients known to be mildly to moderately demented versus 24 age-matched normal controls (to establish cutoff standards); and (2) a "real world" sample of 26 elderly patients not known to be demented, attending a general medicine clinic. The sensitivity and specificity of CAST were compared with the Mini-Mental State Examination (MMSE) and the Blessed Dementia Scale cognitive portion (BDS-cog). In study 1, controls were given a detailed neuropsychological battery; in study 2, all patients were given the neuropsychological battery, which served as the "gold standard" to identify individuals with cognitive impairment. In study 1, the cutoff scores for dementia using CAST (Parts A and B) were established. CAST discriminated demented patients from controls with a sensitivity of 95% and a specificity of 88%; the MMSE had a sensitivity of 74% and a specificity of 100%; and the BDS-cog had a sensitivity of 100% and a specificity of 96%. In study 2, CAST discriminated cognitive impairment with a sensitivity of 88% and a specificity of 100%, the MMSE had a sensitivity of 38% and a specificity of 100%; and the BDS-cog had a sensitivity of 50% and a specificity of 94%. Part C was not used to discriminate demented from normal elderly individuals, but to screen for those concerned about their cognitive functioning. CAST is highly useful as a dementia screening test, with sensitivity and specificity equal to or better than the MMSE and BDS-cog, yet requiring minimal examiner time and little training or experience to administer.

Entities:  

Mesh:

Year:  1996        PMID: 8970013     DOI: 10.1177/089198879600900407

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  10 in total

Review 1.  A review of screening tests for cognitive impairment.

Authors:  Breda Cullen; Brian O'Neill; Jonathan J Evans; Robert F Coen; Brian A Lawlor
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-12-18       Impact factor: 10.154

2.  Neurocognitive Correlates of Resilience in Late-Life Depression.

Authors:  Kelsey T Laird; Helen Lavretsky; Pauline Wu; Beatrix Krause; Prabha Siddarth
Journal:  Am J Geriatr Psychiatry       Date:  2018-08-25       Impact factor: 4.105

Review 3.  Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Complications and Quality of Life Working Party of the European Society for Blood and Marrow Transplantation.

Authors:  Debra Lynch Kelly; David Buchbinder; Rafael F Duarte; Jeffrey J Auletta; Neel Bhatt; Michael Byrne; Zachariah DeFilipp; Melissa Gabriel; Anuj Mahindra; Maxim Norkin; Helene Schoemans; Ami J Shah; Ibrahim Ahmed; Yoshiko Atsuta; Grzegorz W Basak; Sara Beattie; Sita Bhella; Christopher Bredeson; Nancy Bunin; Jignesh Dalal; Andrew Daly; James Gajewski; Robert Peter Gale; John Galvin; Mehdi Hamadani; Robert J Hayashi; Kehinde Adekola; Jason Law; Catherine J Lee; Jane Liesveld; Adriana K Malone; Arnon Nagler; Seema Naik; Taiga Nishihori; Susan K Parsons; Angela Scherwath; Hannah-Lise Schofield; Robert Soiffer; Jeff Szer; Ida Twist; Anne Warwick; Baldeep M Wirk; Jean Yi; Minoo Battiwalla; Mary E Flowers; Bipin Savani; Bronwen E Shaw
Journal:  Biol Blood Marrow Transplant       Date:  2017-09-20       Impact factor: 5.742

4.  Emotional and cognitive health correlates of leisure activities in older Latino and Caucasian women.

Authors:  Angelica P Herrera; Thomas W Meeks; Sharron E Dawes; Dominique M Hernandez; Wesley K Thompson; David H Sommerfeld; Matthew A Allison; Dilip V Jeste
Journal:  Psychol Health Med       Date:  2011-05-24       Impact factor: 2.423

5.  Measurement and predictors of resilience among community-dwelling older women.

Authors:  Amanda J Lamond; Colin A Depp; Matthew Allison; Robert Langer; Jennifer Reichstadt; David J Moore; Shahrokh Golshan; Theodore G Ganiats; Dilip V Jeste
Journal:  J Psychiatr Res       Date:  2008-05-01       Impact factor: 4.791

Review 6.  Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT.

Authors:  David Buchbinder; Debra Lynch Kelly; Rafael F Duarte; Jeffery J Auletta; Neel Bhatt; Michael Byrne; Zachariah DeFilipp; Melissa Gabriel; Anuj Mahindra; Maxim Norkin; Helene Schoemans; Ami J Shah; Ibrahim Ahmed; Yoshiko Atsuta; Grzegorz W Basak; Sara Beattie; Sita Bhella; Christopher Bredeson; Nancy Bunin; Jignesh Dalal; Andrew Daly; James Gajewski; Robert Peter Gale; John Galvin; Mehdi Hamadani; Robert J Hayashi; Kehinde Adekola; Jason Law; Catherine J Lee; Jane Liesveld; Adriana K Malone; Arnon Nagler; Seema Naik; Taiga Nishihori; Susan K Parsons; Angela Scherwath; Hannah-Lise Schofield; Robert Soiffer; Jeff Szer; Ida Twist; Anne B Warwick; Baldeep M Wirk; Jean Yi; Minoo Battiwalla; Mary D E Flowers; Bipin Savani; Bronwen E Shaw
Journal:  Bone Marrow Transplant       Date:  2018-01-17       Impact factor: 5.483

Review 7.  Review of brief cognitive tests for patients with suspected dementia.

Authors:  Latha Velayudhan; Seung-Ho Ryu; Malgorzata Raczek; Michael Philpot; James Lindesay; Matthew Critchfield; Gill Livingston
Journal:  Int Psychogeriatr       Date:  2014-03-31       Impact factor: 3.878

8.  The use of the Hungarian Test Your Memory (TYM-HUN), MMSE, and ADAS-Cog tests for patients with mild cognitive impairment (MCI) in a Hungarian population: a cross-sectional study.

Authors:  Szabolcs Garbóczy; Éva Magócs; Gergő József Szőllősi; Szilvia Harsányi; Anikó Égerházi; László Róbert Kolozsvári
Journal:  BMC Psychiatry       Date:  2020-12-01       Impact factor: 3.630

9.  Cumulative effect of simvastatin, L-arginine, and tetrahydrobiopterin on cerebral blood flow and cognitive function in Alzheimer's disease.

Authors:  Elizabeth Degrush; Mohammed Salman Shazeeb; David Drachman; Zeynep Vardar; Clifford Lindsay; Matthew J Gounis; Nils Henninger
Journal:  Alzheimers Res Ther       Date:  2022-09-17       Impact factor: 8.823

Review 10.  Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations.

Authors:  Sam T Creavin; Susanna Wisniewski; Anna H Noel-Storr; Clare M Trevelyan; Thomas Hampton; Dane Rayment; Victoria M Thom; Kirsty J E Nash; Hosam Elhamoui; Rowena Milligan; Anish S Patel; Demitra V Tsivos; Tracey Wing; Emma Phillips; Sophie M Kellman; Hannah L Shackleton; Georgina F Singleton; Bethany E Neale; Martha E Watton; Sarah Cullum
Journal:  Cochrane Database Syst Rev       Date:  2016-01-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.